SNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell Disease

• click to rate

  Posted by Two Blokes Jun 4 - Filed in Stock - 6 views
  
  Sanofi's rilzabrutinib earns its fourth orphan drug status from the FDA, this time targeting sickle cell disease.